| Product Code: ETC7756318 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Jordan Clinical Oncology Next Generation Sequencing Market Overview |
3.1 Jordan Country Macro Economic Indicators |
3.2 Jordan Clinical Oncology Next Generation Sequencing Market Revenues & Volume, 2021 & 2031F |
3.3 Jordan Clinical Oncology Next Generation Sequencing Market - Industry Life Cycle |
3.4 Jordan Clinical Oncology Next Generation Sequencing Market - Porter's Five Forces |
3.5 Jordan Clinical Oncology Next Generation Sequencing Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.6 Jordan Clinical Oncology Next Generation Sequencing Market Revenues & Volume Share, By Workflow, 2021 & 2031F |
3.7 Jordan Clinical Oncology Next Generation Sequencing Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 Jordan Clinical Oncology Next Generation Sequencing Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Jordan Clinical Oncology Next Generation Sequencing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in Jordan |
4.2.2 Growing adoption of personalized medicine in oncology |
4.2.3 Technological advancements in next generation sequencing techniques |
4.3 Market Restraints |
4.3.1 High cost associated with next generation sequencing technology |
4.3.2 Limited awareness and infrastructure for clinical oncology next generation sequencing in Jordan |
5 Jordan Clinical Oncology Next Generation Sequencing Market Trends |
6 Jordan Clinical Oncology Next Generation Sequencing Market, By Types |
6.1 Jordan Clinical Oncology Next Generation Sequencing Market, By Technology |
6.1.1 Overview and Analysis |
6.1.2 Jordan Clinical Oncology Next Generation Sequencing Market Revenues & Volume, By Technology, 2021- 2031F |
6.1.3 Jordan Clinical Oncology Next Generation Sequencing Market Revenues & Volume, By Whole Genome Sequencing, 2021- 2031F |
6.1.4 Jordan Clinical Oncology Next Generation Sequencing Market Revenues & Volume, By Whole Exome Sequencing, 2021- 2031F |
6.1.5 Jordan Clinical Oncology Next Generation Sequencing Market Revenues & Volume, By Targeted Sequencing, 2021- 2031F |
6.1.6 Jordan Clinical Oncology Next Generation Sequencing Market Revenues & Volume, By Resequencing, 2021- 2031F |
6.2 Jordan Clinical Oncology Next Generation Sequencing Market, By Workflow |
6.2.1 Overview and Analysis |
6.2.2 Jordan Clinical Oncology Next Generation Sequencing Market Revenues & Volume, By NGS Pre-Sequencing, 2021- 2031F |
6.2.3 Jordan Clinical Oncology Next Generation Sequencing Market Revenues & Volume, By NGS Sequencing, 2021- 2031F |
6.2.4 Jordan Clinical Oncology Next Generation Sequencing Market Revenues & Volume, By NGS Data Analysis, 2021- 2031F |
6.3 Jordan Clinical Oncology Next Generation Sequencing Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 Jordan Clinical Oncology Next Generation Sequencing Market Revenues & Volume, By Screening, 2021- 2031F |
6.3.3 Jordan Clinical Oncology Next Generation Sequencing Market Revenues & Volume, By Companion Diagnostics, 2021- 2031F |
6.3.4 Jordan Clinical Oncology Next Generation Sequencing Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Jordan Clinical Oncology Next Generation Sequencing Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Jordan Clinical Oncology Next Generation Sequencing Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 Jordan Clinical Oncology Next Generation Sequencing Market Revenues & Volume, By Clinics, 2021- 2031F |
6.4.4 Jordan Clinical Oncology Next Generation Sequencing Market Revenues & Volume, By Laboratories, 2021- 2031F |
6.4.5 Jordan Clinical Oncology Next Generation Sequencing Market Revenues & Volume, By Others, 2021- 2031F |
7 Jordan Clinical Oncology Next Generation Sequencing Market Import-Export Trade Statistics |
7.1 Jordan Clinical Oncology Next Generation Sequencing Market Export to Major Countries |
7.2 Jordan Clinical Oncology Next Generation Sequencing Market Imports from Major Countries |
8 Jordan Clinical Oncology Next Generation Sequencing Market Key Performance Indicators |
8.1 Average turnaround time for next generation sequencing tests in clinical oncology |
8.2 Rate of adoption of next generation sequencing in clinical oncology practices in Jordan |
8.3 Number of clinical trials incorporating next generation sequencing technology in Jordan |
9 Jordan Clinical Oncology Next Generation Sequencing Market - Opportunity Assessment |
9.1 Jordan Clinical Oncology Next Generation Sequencing Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.2 Jordan Clinical Oncology Next Generation Sequencing Market Opportunity Assessment, By Workflow, 2021 & 2031F |
9.3 Jordan Clinical Oncology Next Generation Sequencing Market Opportunity Assessment, By Application, 2021 & 2031F |
9.4 Jordan Clinical Oncology Next Generation Sequencing Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Jordan Clinical Oncology Next Generation Sequencing Market - Competitive Landscape |
10.1 Jordan Clinical Oncology Next Generation Sequencing Market Revenue Share, By Companies, 2024 |
10.2 Jordan Clinical Oncology Next Generation Sequencing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here